Posted on May 24, 2009 by Sitemaster
Today’s news reports deal with such matters as:
- Advances in radical prostatectomy
- Variations in mutation in androgen-resistant patients
- Data from a Phase I/II trial of AT-101
- The link between CTC level and response to therapy with abiraterone … READ MORE …
Filed under: Drugs in development, Management, Treatment, Uncategorized | Tagged: abiraterone, androgen resistance, AT-101, CTC, ERG, mutation, radical prostatectomy | Leave a comment »
Posted on February 13, 2009 by Sitemaster
After a relatively quiet news period, the flood gates have opened again, so we shall divide today’s news reports into two postings for easier reading. We have also published a separate report on the possibility of an association between alcohol use and prostate cancer diagnosis. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: active surveillance, aggressiveness, androgen resistance, avanafil, ED, erectile dysfunction, p63, prognosis, survival, vitamin D | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 